Literature DB >> 4677928

Amantadine in Parkinson's disease. Review of more than two years' experience.

R S Schwab, D C Poskanzer, A C England, R R Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4677928     DOI： 10.1001/jama.222.7.792

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  27 in total

Review 1.  Amantadine for fatigue in multiple sclerosis.

Authors:  E Pucci; P Branãs; R D'Amico; G Giuliani; A Solari; C Taus
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency.

Authors:  T S Ing; S D Mahurkar; G Dunea; J A Hayashi; H L Klawans; W S Markey
Journal:  Can Med Assoc J       Date:  1976-09-18       Impact factor: 8.262

Review 3.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

Review 4.  Drug Repurposing in Parkinson's Disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

Review 5.  Drugs and depression.

Authors:  F A Whitlock; L E Evans
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

6.  An extended clinical trial to compare levodopa and amantadine used as single drugs with both drugs used incombination in Parkinson's Disease.

Authors:  N Calaghan; M McIlroy; M O'Connor
Journal:  Ir J Med Sci       Date:  1974-03       Impact factor: 1.568

7.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

8.  Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations.

Authors:  M Brenner; A Haass; P Jacobi; K Schimrigk
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

9.  Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.

Authors:  Phillip C Eckels; Anirban Banerjee; Ernest E Moore; Nathan J D McLaughlin; Lynn M Gries; Marguerite R Kelher; Kelly M England; Fabia Gamboni-Robertson; Samina Y Khan; Christopher C Silliman
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-18       Impact factor: 4.249

10.  Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.

Authors:  G M Pacifici; M Nardini; P Ferrari; R Latini; C Fieschi; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.